CoChat

Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm

Open access
McCormack, Francis X., Travis, William D., Colby, Thomas V., Henske, Elizabeth P., Moss, Joel · 2012 · American Journal of Respiratory and Critical Care Medicine
Cited by 200

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease primarily affecting women that has historically been classified and clinically managed as a nonneoplastic interstitial lung disease.The purpose of this document is to outline the accumulating data that support reclassification of LAM as a low-grade, destructive, metastasizing neoplasm.This major conceptual shift actually began more than 10 years ago in the pathology community.The 1999 World Health Organization classification of lung tumors regarded LAM as a "tumour-like" lesion, and in the 2004 classification, it was codified as a mesenchymal neoplasm (1, 2).The pulmonary community seems to have been slower to adopt this viewpoint, however, and continues to consider LAM one of the "other" idiopathic interstitial pneumonias.LAM occurs in patients with tuberous sclerosis complex (TSC) and also as a sporadic illness in patients without heritable disease.In either case, the smooth muscle-like "LAM cells" that diffusely infiltrate the lungs, lymphatics, and angiomyolipomas of patients with LAM have a low proliferative index and little or no evidence of cellular atypia, suggestive of a benign process.However, mounting genetic and cellular evidence has shown that, despite their innocent appearance, LAM cells exhibit the features and behaviors of a neoplasm.The finding of loss of heterozygosity for tuberous sclerosis complex genes in the lung, kidney, and lymphatic lesions of patients with LAM is consistent with clonal origins for these tumors.In the handful of patients who have had multiple tissues available for sequencing, identical TSC mutations found in the angiomyolipomas, lymph nodes, and lungs are indicative of seeding from a common, most likely extrapulmonary source (3).Angiomyolipomas have been proposed as a potential primary tumor, but they are present in a minority of patients with sporadic LAM (4).The expression of smooth muscle markers (5) and steroid hormone (estrogen and progesterone) receptors ( 6), variation of symptoms with the menstrual cycle (7), and report of LAM lesions in 9 of 10 resected uterine specimens from patients with LAM in a small series (8) are potentially consistent with a uterine primary tumor, at least in some patients.The TSC mutations that occur in LAM result in inappropriate, constitutive signaling through the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201205-0848oe

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 200

Metadata

Authors
McCormack, F. X., Travis, W. D., Colby, T. V., Henske, E. P., & Moss, J.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2012-12-15
Volume
186
Issue
12
Pages
1210-1212
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1969798989
Cited by
200
References
2
FWCI
8.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm. https://app.cochat.ai/papers/10.1164/rccm.201205-0848oe
The paper
McCormack, F. X., Travis, W. D., Colby, T. V., Henske, E. P., & Moss, J. (2012). Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201205-0848oe

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.